CXCR7 anticorps (AA 151-250)
-
- Antigène Voir toutes CXCR7 Anticorps
- CXCR7 (Chemokine (C-X-C Motif) Receptor 7 (CXCR7))
-
Épitope
- AA 151-250
-
Reactivité
- Humain, Rat
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp CXCR7 est non-conjugé
-
Application
- Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunocytochemistry (ICC)
- Réactivité croisée
- Humain, Rat
- Homologie
- Mouse,Dog,Cow,Pig,Horse,Rabbit
- Purification
- Purified by Protein A.
- Immunogène
- KLH conjugated synthetic peptide derived from human CXCR7/RDC1
- Isotype
- IgG
- Top Product
- Discover our top product CXCR7 Anticorps primaire
-
-
- Indications d'application
-
WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200
ICC 1:100-500 - Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 μg/μL
- Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
- Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Stock
- 4 °C,-20 °C
- Stockage commentaire
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
- Date de péremption
- 12 months
-
-
MicroRNA-100 suppresses human gastric cancer cell proliferation by targeting CXCR7." dans: Oncology letters, Vol. 15, Issue 1, pp. 453-458, (2018) (PubMed).
: "
-
MicroRNA-100 suppresses human gastric cancer cell proliferation by targeting CXCR7." dans: Oncology letters, Vol. 15, Issue 1, pp. 453-458, (2018) (PubMed).
-
- Antigène
- CXCR7 (Chemokine (C-X-C Motif) Receptor 7 (CXCR7))
- Autre désignation
- CXCR7/RDC1 (CXCR7 Produits)
- Synonymes
- anticorps CMKOR1, anticorps CXC-R7, anticorps CXCR-7, anticorps CXCR7, anticorps GPR159, anticorps RDC-1, anticorps RDC1, anticorps AW541270, anticorps Cmkor1, anticorps Cxcr7, anticorps Rdc1, anticorps ackr3, anticorps cxcr7, anticorps rdc1, anticorps xcxcr7, anticorps atypical chemokine receptor 3, anticorps ORF 74; similar to Kaposi's sarcoma-associated herpesvirus ORF 74, anticorps atypical chemokine receptor 3 L homeolog, anticorps ACKR3, anticorps MmrVgp88, anticorps Ackr3, anticorps ackr3.L
- Sujet
-
Synonyms: RDC1, CXCR7, RDC-1, CMKOR1, CXC-R7, CXCR-7, GPR159, Atypical chemokine receptor 3, C-X-C chemokine receptor type 7, Chemokine orphan receptor 1, G-protein coupled receptor 159, G-protein coupled receptor RDC1 homolog, ACKR3
Background: Atypical chemokine receptor that controls chemokine levels and localization via high-affinity chemokine binding that is uncoupled from classic ligand-driven signal transduction cascades, resulting instead in chemokine sequestration, degradation, or transcytosis. Also known as interceptor (internalizing receptor) or chemokine-scavenging receptor or chemokine decoy receptor. Acts as a receptor for chemokines CXCL11 and CXCL12/SDF1. Chemokine binding does not activate G-protein-mediated signal transduction but instead induces beta-arrestin recruitment, leading to ligand internalization and activation of MAPK signaling pathway. Required for regulation of CXCR4 protein levels in migrating interneurons, thereby adapting their chemokine responsiveness. In glioma cells, transduces signals via MEK/ERK pathway, mediating resistance to apoptosis. Promotes cell growth and survival. Not involved in cell migration, adhesion or proliferation of normal hematopoietic progenitors but activated by CXCL11 in malignant hemapoietic cells, leading to phosphorylation of ERK1/2 (MAPK3/MAPK1) and enhanced cell adhesion and migration. Plays a regulatory role in CXCR4-mediated activation of cell surface integrins by CXCL12. Required for heart valve development. Acts as coreceptor with CXCR4 for a restricted number of HIV isolates.
- ID gène
- 57007
- UniProt
- P25106
- Pathways
- Myometrial Relaxation and Contraction, Negative Regulation of intrinsic apoptotic Signaling
-